Compound Detail
CHEMBL267044
LEVOSULPIRIDE 🧪 Phase II
Enter ChEMBL ID:
Free Research Context
This compound will appear in recent viewed items on the research home for this browser.
Research home
View demo workspace
🧪 Phase II
Basic Information
| ChEMBL ID | CHEMBL267044 |
| Name | LEVOSULPIRIDE |
| Phase | Phase II |
| Structure Type | MOL |
| InChI Key | BGRJTUBHPOOWDU-NSHDSACASA-N |
9
Targets
27
Activities
2
Assay Types
0
PK Parameters
20
Publications
12
Known Names
3
Indications
2
Mechanisms
Molecular Properties
341.4
MW (Da)
0.56
ALogP
5
HBA
2
HBD
101.7
PSA (Ų)
0.79
QED
0
Ro5 Violations
6
Rot. Bonds
Drug Information
| Molecule Type | Small molecule |
| Chirality | Single Enantiomer |
Mechanism of Action
| Mechanism | Action Type | Target | Direct | Efficacy |
|---|---|---|---|---|
| Dopamine D2 receptor antagonist | ANTAGONIST | D(2) dopamine receptor | ✓ | ✓ |
| Serotonin 4 (5-HT4) receptor agonist | AGONIST | 5-hydroxytryptamine receptor 4 | ✓ | ✓ |
Indications
Psychomotor Agitation Psychotic Disorders Dyspepsia
ATC Classification
N05AL07
levosulpiride
Level 1: NERVOUS SYSTEM
Level 2: PSYCHOLEPTICS
Activity Summary
Ki 19 meas. best 8.16
IC50 8 meas. best 6.91
Target Activity Profile
| Target | Type | Best pChEMBL | Mean pChEMBL | Best (nM) | # Data |
|---|---|---|---|---|---|
| D(2) dopamine receptor CHEMBL339 | Ki | 8.16 | 7.642 | 6.9 | 5 |
| D(3) dopamine receptor CHEMBL234 | Ki | 7.38 | 7.1667 | 42.0 | 3 |
| D(2) dopamine receptor CHEMBL217 | Ki | 7.37 | 7.158 | 43.0 | 5 |
| D(3) dopamine receptor CHEMBL234 | IC50 | 6.91 | 6.91 | 123.0 | 1 |
| D(2) dopamine receptor CHEMBL217 | IC50 | 6.89 | 6.89 | 128.0 | 1 |
| D(2) dopamine receptor CHEMBL339 | IC50 | 6.77 | 6.6933 | 170.0 | 3 |
| Dopamine receptor CHEMBL2093868 | IC50 | 6.68 | 6.68 | 210.0 | 1 |
| D(4) dopamine receptor CHEMBL219 | Ki | 5.68 | 5.68 | 2100.0 | 2 |
| Myeloperoxidase CHEMBL2439 | IC50 | 5.12 | 5.12 | 7680.0 | 1 |
| Adrenergic receptor alpha-1 CHEMBL1907610 | Ki | 4.82 | 4.82 | 15000.0 | 1 |
| Serotonin 2 (5-HT2) receptor CHEMBL2093870 | Ki | 4.57 | 4.57 | 27000.0 | 1 |
| D(1A) dopamine receptor CHEMBL2967 | Ki | 4.3 | 4.3 | 50000.0 | 2 |
Activity Data Samples
Top measurements by pChEMBL value
Literature References
| PubMed | DOI | Target Context | # Activities |
|---|---|---|---|
| - | 10.6019/CHEMBL3885881 | Rattus norvegicus | 143 |
| - | 10.6019/CHEMBL4495565 | SARS-CoV-2 | 6 |
| 1969484 | 10.1021/jm00166a012 | Rattus norvegicus | 4 |
| 3761301 | 10.1021/jm00160a003 | Carbonic anhydrase | 4 |
| - | 10.6019/CHEMBL4808148 | Histone deacetylase 6 | 4 |
| 37468498 | 10.1038/s41467-023-40064-9 | D(1A) dopamine receptor | 3 |
| 37468498 | 10.1038/s41467-023-40064-9 | Alpha-2A adrenergic receptor | 3 |
| 37468498 | 10.1038/s41467-023-40064-9 | 5-hydroxytryptamine receptor 2A | 3 |
| - | 10.6019/CHEMBL4495564 | Replicase polyprotein 1ab | 3 |
| 37468498 | 10.1038/s41467-023-40064-9 | Cannabinoid receptor 1 | 3 |
| 1535660 | 10.1021/jm00091a002 | D(2) dopamine receptor | 3 |
| 37468498 | 10.1038/s41467-023-40064-9 | Histamine H1 receptor | 3 |
| 37468498 | 10.1038/s41467-023-40064-9 | Alpha-1A adrenergic receptor | 3 |
| 1969484 | 10.1021/jm00166a012 | D(2) dopamine receptor | 2 |
| 37468498 | 10.1038/s41467-023-40064-9 | Beta-2 adrenergic receptor | 2 |
| 10987445 | 10.1016/s0960-894x(00)00405-4 | D(2) dopamine receptor | 2 |
| 9464359 | 10.1021/jm970217c | Rattus norvegicus | 2 |
| - | 10.21203/rs.3.rs-23951/v1 | SARS-CoV-2 | 2 |
| 37468498 | 10.1038/s41467-023-40064-9 | 5-hydroxytryptamine receptor 2B | 2 |
| 1346653 | 10.1021/jm00081a018 | Rattus norvegicus | 2 |
Data from ChEMBL 36 via Core Engine